In vivo detection of hypothalamic glucose metabolism in HFD and regular fed mice
Blanca Lizarbe1, Antonie Cherix1, Lijing Xin2, Hongxia Lei2,3, and Rolf Gruetter1,3,4

1Laboratory for Functional and Metabolic Imaging (LIFMET), Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland, 2Animal imaging and technology core (AIT), Center for Biomedical Imaging (CIBM), Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland, Lausanne, Switzerland, 3Department of Radiology, University of Geneva, Geneva, Switzerland, 4Department of Radiology, University of Lausanne, Lausanne, Switzerland

Synopsis

Obesity is a pandemic syndrome that leads to reduced life expectancy, increasing the risk of heart disease, type-2 diabetes and some type of cancers. Noteworthy, to understand the mechanisms of obesity onset and development, several animal models, such as administration high fat diets, have been developed. We used 1H-[13C] MRS methods in regular and in high fat diet fed mice to investigate the effects of high caloric diets and obesity in the hypothalamus, its effects in glucose metabolism and metabolic fluxes in neurons and glia. We found differences that suggest impaired glucose metabolism in the hypothalamus of obese mice.

PURPOSE

Recent investigations have associated consumption of high fat diets (HFD) with inflammation in the hypothalamus, the main cerebral regulator of energy balance in the brain, reporting processes as astroglisosis and neuronal injury at a local level1. The implementation of a technique capable of detecting in vivo the changes in metabolites, neurotransmitters and metabolic fluxes in the hypothalamus, could represent an excellent strategy with which to investigate the physiologic and pathologic conditions of the mouse brain. Thus, the aim of this study was to follow the incorporation of 13C-labeled glucose into its metabolites in the hypothalamus of mice fed regular diet or high fat diet using 1H-[13C] MRS methods, and investigate the HFD induced effects on glucose metabolites and neuroglial metabolic fluxes.

METHODS

C57BL/6 mice (12weeks old, n=3, 28.5±1.2g) were fed with a 60% kcal fat diet (http://www.researchdiets.com) during two months or with regular food chow (13 weeks old, n=5, 28.6±1g). Animals were fasted overnight (12h) before experiments, and body weight and blood glucose levels were controlled in each experimental session. All MR measurements were performed in a horizontal 14.1T/26cm Varian Magnet, using a homemade 1H quadrature surface coil (12mm diameter) combined with a linear 13C coil (11 mm diameter). The hypothalamus voxel (1.8x2.7x1.8 mm3) was selected based on anatomical MR images and using a mouse brain atlas as a reference2 and field homogeneity was improved using FASTMAP methods3. Indirect 1H-[13C] detection was achieved using the full signal intensity NMR sequence BISEP-SPECIAL4combined with OVS and VAPOR water supression5. Hypothalamic glucose (Glc) metabolism was evaluated during the infusion of [1,6-13C2] glucose solution (20% w/v , bolus= 9mL/kg, infusion rate= 15mL/kg/h). To increase the SNR, spectra of all animals’ from the same group were added together every 13 min of acquisition, and metabolites were quantified using LCModel. Non-edited 1H MR spectra acquired with 13C decoupling but without 13C editing contain 1H resonances coupled to both 12C and 13C and thus can be quantified with a standard basis set for neurochemical profiles of mouse hypothalamus. The 13C-editing spectra were quantified using another simulated basis set as previously4. The fraction of isotope enrichment (FE) in lactate (Lac), glutamate (Glu), glutamine (Gln) and g-amino-butyrate (GABA) were estimated. Time course of Glu C4, Gln C4 and Glx C3 was fitted to a one compartment model of glucose metabolism using MATLAB nonlinear regression methods, and TCA rate (Vtca), transmitocondrial flux (Vx), neurotransmission rate (Vnt), dilution factor (Kdil) and composite flux (Vgt) were estimated. The errors of all adjusted metabolic fluxes were evaluated by Monte–Carlo simulation6.

RESULTS

Body weight of HFD fed and control animals before the MRS measurements (fasting state) (45.8±2.6g, 25.6±1g) were significantly different (p<0.005, t-test) as well as their fasting blood glucose levels (13±1.2mmol, 5.25±1.2 mmol). Figure 1 shows representative non-edited and edited hypothalamic spectra in control animals after 160 min of infusion of labeled glucose: note the high levels of GABA, a typical feature of the mouse hypothalamus7. SNR of the edited spectra was >5 for all cases, as measured from LCModel, and linewidths of total creatine at 3.0ppm <20Hz. Figure 2 depicts the time course of the 13C label accumulation in the same animals, and the calculated FE for HFD and control animals is illustrated in Figure 3. FE of Lac C3, which depicts a similar turnover in both groups, was used as an input function for the metabolic fluxes quantification. The total pool size of the metabolites was also measured along the glucose infusion, and values are summarized in Figure 4. Glc and Asp show higher values in the HFD group and GABA and Lac higher in the control group (p<0.001 in all cases, t-test). Finally, derived metabolic fluxes are illustrated in Figure 5. Calculated values show similar Vtca rates for both animal groups, higher Vx and Vgt for the HFD animals and higher Vnt and Kdil for the control group.

DISCUSSION

Indirect 1H-[13C] detection revealed the incorporation of 13C-labeled glucose in vivo into a number of metabolites of biological importance in the hypothalamus. We show for the first time, in vivo reliable measurements of the turnover of Lac C3, Glu C4, Gln C4, Glu C3, Gln C3, GABA C4, GABA C3 in the mouse hypothalamus. HDF animals, which show prediabetic fasting blood glucose levels, display increased Glc and Asp levels and decreased Lac and GABA levels in the hypothalamus, as compared to regular fed animals. Moreover, the increased Vx and decreased Vnt and Kdil highlight putative alterations in glucose metabolism.

Acknowledgements

Authors want to thank B. Lanz and J. Duarte for his help in the modeling process and interpretation of results. The work is supported by the CIBM of the UNIL, UNIGE, HUG; CHUV, EPFL and Leenaards and Louis-Jeantet Foundations.

References

1Thaler JP, J. Clin. Invest. (2012);2 Paxinos G. (2001) ;3Gruetter R et al. Magn.Reson.Med (2000);4Xin et al. Magn.Reson.Med.(2010);5Tkac I Magn.Reson.Med.(2009);6 Lanz, B. Front. Endocrinol (2013); 7Lei H. et al. NMR Biomed (2010).

Figures

Non-edited (top) and edited (bottom, lb=5Hz) spectra after summing spectrum from 4 animals during 13 min, 160 min after glucose infusion started.

Time course of the accumulation of 13C label from [1,6-13C2] glucose into its metabolites in control animals.

Time course of the FE of Glc and its metabolic products in the hypothalamus of control and HFD fed animals.

Mean values (±SD) of metabolites in the hypothalamus of HFD (red) and control (blue) animals measured during the glucose infusion.

Metabolic fluxes (mean±SD obtained in MC simulations) in control and HFD fed animals.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
0110